179 related articles for article (PubMed ID: 19300145)
1. High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference?
Boyle MH; McGwin G; Flanagan CE; Vicinanzo MG; Long JA
Ophthalmic Plast Reconstr Surg; 2009; 25(2):81-4. PubMed ID: 19300145
[TBL] [Abstract][Full Text] [Related]
2. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
Lolekha P; Choolam A; Kulkantrakorn K
Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pain scores with 30-gauge and 32-gauge needles for periocular botulinum toxin type a injections.
Yomtoob DE; Dewan MA; Lee MS; Harrison AR
Ophthalmic Plast Reconstr Surg; 2009; 25(5):376-7. PubMed ID: 19966651
[TBL] [Abstract][Full Text] [Related]
5. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
[TBL] [Abstract][Full Text] [Related]
6. Pain relief in patients receiving periocular botulinum toxin A.
Harrison AR; Erickson JP; Anderson JS; Lee MS
Ophthalmic Plast Reconstr Surg; 2008; 24(2):113-6. PubMed ID: 18356715
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm.
Nüssgens Z; Roggenkämper P
Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):197-9. PubMed ID: 9143885
[TBL] [Abstract][Full Text] [Related]
8. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
[TBL] [Abstract][Full Text] [Related]
9. Skin cooling before periocular botulinum toxin A injection.
Linder JS; Edmonson BC; Laquis SJ; Drewry RD; Fleming JC
Ophthalmic Plast Reconstr Surg; 2002 Nov; 18(6):441-2. PubMed ID: 12439058
[TBL] [Abstract][Full Text] [Related]
10. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
[TBL] [Abstract][Full Text] [Related]
11. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm.
Truong DD; Gollomp SM; Jankovic J; LeWitt PA; Marx M; Hanschmann A; Fernandez HH;
J Neural Transm (Vienna); 2013 Sep; 120(9):1345-53. PubMed ID: 23435927
[TBL] [Abstract][Full Text] [Related]
12. Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection.
Kocabeyoglu S; Sekeroglu HT; Mocan MC; Muz E; Irkec M; Sanac AS
Eur J Ophthalmol; 2014; 24(6):830-4. PubMed ID: 24803156
[TBL] [Abstract][Full Text] [Related]
13. Use of high-dose botulinum A toxin in benign essential blepharospasm: is too high too much?
Pang AL; O'Day J
Clin Exp Ophthalmol; 2006 Jul; 34(5):441-4. PubMed ID: 16872340
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Safety and Efficacy of Botox and Neuronox in the Management of Benign Essential Blepharospasm: A Split-face Study.
Sane S; Ali MJ; Naik MN
Korean J Ophthalmol; 2019 Oct; 33(5):430-435. PubMed ID: 31612653
[TBL] [Abstract][Full Text] [Related]
15. Riolan's muscle: action and indications for botulinum toxin injection.
Mackie IA
Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
[TBL] [Abstract][Full Text] [Related]
16. [Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use].
Sheen-Ophir S; Almog Y
Harefuah; 2013 Feb; 152(2):98-100, 123, 122. PubMed ID: 23513501
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of individualized botulinum neurotoxin type A injection techniques in patients with essential blepharospasm.
Sung Y; Nam SM; Lew H
Korean J Ophthalmol; 2015 Apr; 29(2):115-20. PubMed ID: 25829828
[TBL] [Abstract][Full Text] [Related]
18. Comparison of techniques of botulinum toxin injections for blepharospasm and hemifacial spasm.
Sacramento DRC; Lima A; Maia DP; Cunningham M; Maciel RH; Camargos ST; Cardoso F
Mov Disord; 2019 Sep; 34(9):1401-1403. PubMed ID: 31251420
[No Abstract] [Full Text] [Related]
19. Myobloc for the treatment of benign essential blepharospasm in patients refractory to botox.
Dutton JJ; White JJ; Richard MJ
Ophthalmic Plast Reconstr Surg; 2006; 22(3):173-7. PubMed ID: 16714924
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
Wu CJ; Shen JH; Chen Y; Lian YJ
Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]